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Abstract
Background Numerous meta-analyses have investigated
the effect of exercise in different populations and for single
cardiovascular risk factors, but none have specifically
focused on the metabolic syndrome (MetS) patients and the
concomitant effect of exercise on all associated cardio-
vascular risk factors.
Objective The aim of this article was to perform a sys-
tematic review with a meta-analysis of randomized and
clinical controlled trials (RCTs, CTs) investigating the
effect of exercise on cardiovascular risk factors in patients
with the MetS.
Methods RCTs and CTs C4 weeks investigating the
effect of exercise in healthy adults with the MetS and
published in a peer-reviewed journal up to November 2011
were included. Primary outcome measures were changes in
waist circumference (WC), systolic and diastolic blood
pressure, high-density lipoprotein cholesterol (HDL-C),
triglycerides and fasting plasma glucose. Peak oxygen
uptake ( _VO2peak) was a secondary outcome. Random and
fixed-effect models were used for analyses and data are
reported as means and 95% confidence intervals (CIs).
Results Seven trials were included, involving nine study
groups and 206 participants (128 in exercise group and 78
in control group). Significant mean reductions in WC -3.4
(95% CI -4.9, -1.8) cm, blood pressure -7.1 (95% CI
-9.03, -5.2)/-5.2 (95% CI -6.2, -4.1) mmHg and a
significant mean increase in HDL-C ?0.06 (95% CI ?0.03,
?0.09) mmol/L were observed after dynamic endurance
training. Mean plasma glucose levels -0.31 (95% CI
-0.64, 0.01; p = 0.06) mmol/L and triglycerides -0.05
(95% CI -0.20, 0.09; p = 0.47) mmol/L remained statis-
tically unaltered. In addition, a significant mean improve-
ment in _VO2peak of ?5.9 (95% CI ?3.03, ?8.7) mL/kg/min
or 19.3% was found.
Conclusions Our results suggest that dynamic endurance
training has a favourable effect on most of the cardiovas-
cular risk factors associated with the MetS. However, in the
search for training programmes that optimally improve
total cardiovascular risk, further research is warranted,
including studies on the effects of resistance training and
combined resistance and endurance training.
1 Introduction
The ‘metabolic syndrome’ (MetS) or ‘syndrome X’ is a
constellation of cardiovascular risk factors including
abdominal obesity, impaired glucose control, hypertension
and dyslipidaemia [1]. The MetS components separately
increase the risk for cardiovascular disease (CVD) and all-
cause mortality, but the full syndrome is associated with an
increase in risk that is greater than the risk of each separate
risk factor [2]. Therapeutic lifestyle changes, including
exercise, are recommended as firstline strategy in the treat-
ment of cardiovascular risk factors [3]. Previous meta-
analyses demonstrated that dynamic endurance exercise
decreases blood pressure (BP) in hypertensive individuals
[4, 5], causes a significant reduction in blood lipids and
lipoproteins in patients with hyperlipidaemia [6, 7], reduces
glycated haemoglobin (HbA1c; percentage) in patients with
type 2 diabetes mellitus [7] and is associated with improved
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body composition in obese individuals [7]. However, to the
best of the authors’ knowledge, meta-analyses have not been
performed to determine the concomitant effect of exercise on
all risk factors of the MetS in patients with the MetS.
Therefore, the aim of this study was to perform a sys-
tematic review with a meta-analysis of RCTs or CTs
investigating the effect of exercise on cardiovascular risk
factors in patients with the MetS.
2 Research Design and Methods
2.1 Literature Search
We conducted a systematic literature search with the
MEDLINE computerized database from its inception to
November 2011 using the following medical subject
headings (MeSH terms): ‘Metabolic Syndrome X’ AND
(‘Exercise’ OR ‘Motor Activities’). A second literature
search was done in MEDLINE using the following title
terms: ‘Metabolic Syndrome’ OR ‘Syndrome X’ AND
‘Exercise’. In addition, the reference lists from published
original and review articles were searched manually to
identify other possible eligible studies.
2.2 Inclusion Criteria
We included studies in the meta-analysis if the following
requirements were met: (i) (RCTs) or CTs investigating the
effect of exercise (dynamic endurance exercise—dynamic
resistance exercise—or a combination); (ii) the duration of
intervention was at least 4 weeks; (iii) intervention in adults
(C18 years) with the MetS (WHO 1998 [8], National Cho-
lesterol Education Program Adult Treatment Panel III
[NCEP/ATP III] 2001 [9] or International Diabetes Federa-
tion [IDF] 2005 [10]) but with no other CVD; (iv) full pub-
lication in a peer-reviewed journal up to November 2011.
2.3 Measured Outcomes
The primary outcomes were changes in cardiovascular risk
factors associated with the MetS: i.e. waist circumference
(WC), fasting plasma glucose, systolic and diastolic blood
pressure (SBP, DBP), high-density lipoprotein cholesterol
(HDL-C) and triglycerides. Secondary outcomes included
peak oxygen uptake ( _VO2peak), body weight, body mass
index (BMI), fat mass, total cholesterol, low-density lipo-
protein cholesterol (LDL-C) and plasma insulin.
2.4 Data Extraction
Two unblinded reviewers (N.P. and S.R.T.E.) indepen-
dently conducted data extraction. A specifically developed
data extraction sheet was used to extract data on study
source, study design, characteristics of the participants, the
exercise characteristics and the different outcomes in each
study. Disagreements were solved by consensus or by a
third reviewer (V.C.).
2.5 Study Quality
Study quality was assessed using an adapted Physiotherapy
Evidence Database (PEDro) scale [11], which is an 11-item
questionnaire designed to collect data on eligibility criteria,
random allocation, concealed allocation, similarity of
baseline values, blinding of therapists and/or assessors, key
outcomes, intent-to-treat analysis, between group differ-
ences, and point and variability measures. We regarded the
quality criteria ‘blinding of participants’ and ‘blinding of
therapists’ as not applicable in exercise intervention stud-
ies, and omitted both criteria. All questions were binary
(yes [1] or no [0]). The minimum score was 0 and the
maximum was 9, with a higher number reflecting a better
study quality. The PEDro-scale has been reported to be
valid and reliable [12, 13].
2.6 Statistical Analysis
Statistical analyses were performed using SAS version
9.3 (SAS Institute, Cary, NC, USA) and Review Manager
Software (RevMan 5.1; Cochrane Collaboration, Oxford,
UK). Descriptive data are reported as mean ± standard
deviation (SD) or median and range. The mean baseline
values were calculated by combining mean values from the
intervention and control groups, weighted by the total
number of participants in each study group. Since we
worked with continuous data, we took the approach of
assuming that randomization would adjust for baseline
differences and used endpoint data only in the meta-ana-
lytical statistics. Each effect was weighted by the inverse of
its variance. The results were combined using fixed and
random effect models and presented with 95% confidence
intervals (CI). Heterogeneity between trial results was
tested with a standard Chi-squared (v2) test. The I2
parameter was used to quantify any inconsistency
(I2 = [(Q - df)] 9 100%, where Q is the v2 statistic and
df are the degrees of freedom). A value for I2 [ 50% has
been considered to be substantial heterogeneity. To
examine the influence of each study on the overall results,
analyses were also performed with each study deleted from
the model. In addition, we performed a simple meta-
regression analysis to investigate whether changes in the
primary outcomes were related to changes in WC. Two-
sided tests for overall effects were considered significant at
p B 0.05. Finally, funnel plots were used to assess the
potential of small publication bias.
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3 Results
3.1 Literature Search
From 822 potentially relevant studies retrieved from our
search, 9 trials met our inclusion criteria [14–22]. A flow
diagram of literature search and selection is presented in
Fig. 1. Two studies were a duplicate of another study, i.e.
using the same population and intervention, and so we
included the most complete publication [17–19, 22].
Hence, seven trials were included in the final analysis.
Some of the trials applied different training regimens [17,
18] so that a total of nine dynamic endurance training
interventions, one dynamic resistance training group and
two combined dynamic endurance/resistance training
groups were available for qualitative analysis. We used the
meta-analytic techniques only on the nine dynamic
endurance training groups.
3.2 Characteristics of the Participants
and Study Designs
Characteristics of the 12 included intervention groups
are summarized in Table 1. All studies were published
between 2003 and 2010. Five of them were RCTs [15, 17,
18, 20, 21] and two of them were CTs [14, 16]. Diagnosis
of the MetS was based on WHO [8] criteria [14, 18], ATP
III [9] criteria [16] or IDF [10] criteria [17, 20, 21]. One
trial [15] used a mixture of the three definitions i.e. stage 1
or 2 hypertension (SBP 140–159 or C160 mmHg; DBP
90–99 or C100 mmHg); plasma insulin concentration
greater than 80 lU/mL ([556 pmol/L) 2 h after the
ingestion of 75 g of glucose; dyslipidaemia, defined as high
triglyceride (C150 mg/dL; C1.7 mmol/L) and/or low
HDL-C levels (men B40 mg/dL; B1.04 mmol/L, women
B50 mg/dL; B1.3 mmol/L).
272 participants were randomized or allocated to an
exercise group (dynamic endurance training, n = 147;
dynamic resistance training, n = 11; combination, n = 32)
or a control group (n = 82). Average drop out was 10%
(range 0–33%), resulting in a total of 245 participants that
could be included in the final analysis: 128 of them com-
pleted a dynamic endurance training intervention, 10
completed a dynamic resistance training intervention, 30
completed a combined intervention and 78 were control
subjects.
Median age was 52 years (range 46–64). Six study trials
included both men and women, and one trial included only
women [17] (±38% and ±41% males in the exercise and
control group, respectively) [15]. Four trials defined ‘not
being sedentary’ as an exclusion criterion [14–17], while
this was not specifically reported in the other three trials
[18, 20, 21]. Two trials did not report on diabetes status,
four study trials excluded individuals with diabetes [14–17]
whereas Balducci et al. [20] included only MetS patients
with diabetes. The use of medication was reported in three
trials [18, 20, 21]; antihypertensive agents, lipid-lowering
agents and oral hypoglycaemic agents or insulin use were
Records identified through
database searching (n = 883)
MeSH terms ‘metabolic syndrome
X AND (exercise OR motor
acitivity)’       (n = 717)
Title terms ‘(metabolic 
syndrome OR syndrome X) 
AND exercise’  (n = 166)
Additional records identified
through other sources (n = 0)
Full-text articles assessed
for eligibility  (n = 9)
Study trials included in quantitative 
analysis   (n = 7)
Intervention groups included in 
quantitative analysis (n = 9)
Study trials included in qualitative
analysis   (n = 7)
Intervention groups included in
qualitative analysis  (n = 12)
Excluded after review of title and
abstract           (n = 874)
 - identical papers          (n = 68)
 - inclusion criteria not
   fulfilled           (n = 797)
Full-text articles not included
because of duplicate
studies           (n = 2)
Fig. 1 Prisma 2009 flow
diagram





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Exercise and Metabolic Syndrome: Meta-Analysis 125
common pharmacotherapy treatments. Three other trials
defined the use of medications as an exclusion criterion
[14, 15, 17]. Gomes et al. [16] defined drugs known to
affect lipoprotein metabolism as an exclusion criterion.
The 12 interventions lasted between 8 and 52 weeks
(median 16). The frequency of training varied between two
and five training sessions weekly (median 3), with an
average of 47.5 min per session (range 40–60). All trials
used walking, jogging or cycling as the modes of exercise.
Two dynamic endurance training groups performed inter-
val training [18, 21], while the other seven endurance
training groups reported using a continuous training pro-
gramme. Intensities ranged from moderate (e.g. ‘maximal
lipid oxidation’) to high (e.g. intervals at 90–95% of heart
rate peak [HRpeak]). The exercise programmes were
supervised in all studies except for Dumortier et al. [14]
where only the first training sessions were supervised and
the patients continued the training at home afterwards.
In Table 2, the results of the adapted PEDro-scale are
represented. The median PEDro score was 6, with a range
from 5 [15, 17] to 8 [20].
3.3 Primary Outcomes: Effect of Exercise
on Cardiovascular Risk Factors Associated
with the Metabolic Syndrome
Dynamic endurance training resulted in a mean reduction
in WC of 3.36 cm (Fig. 2; baseline 104.62; 95% CI -4.87,
-1.84; p \ 0.0001; I2 = 35%), a mean BP decrease of
7.11 (Fig. 3; baseline 137.97; 95% CI -9.03, -5.18;
p \ 0.0001; I2 = 0%) mmHg/5.15 mmHg (Fig. 4; baseline
87.60; 95% CI -6.16, -4.13; p \ 0.0001; I2 = 28%) and
a mean increase in HDL-C of 0.06 (Fig. 5; baseline 1.04;
95% CI ?0.03, ?0.09; p \ 0.0001; I2 = 38%) mmol/L.
By contrast, levels of triglycerides (Fig. 6; -0.05; baseline
2.05; 95% CI -0.20, ?0.09; p = 0.47; I2 = 0%) mmol/L
and plasma glucose (Fig. 7; -0.31; baseline 5.98; 95% CI
-0.64, ?0.01; p = 0.06; I2 = 0%) mmol/L remained sta-
tistically unaltered.
To assess the effect of individual dynamic endurance
studies on the summary estimate we performed a sensi-
tivity analysis, in which the pooled estimates for the dif-
ferent outcomes were recalculated omitting one or two
studies at a time. When we excluded the two aerobic
interval training (AIT) studies, results were similar. How-
ever, when we omitted the only trial in which all patients
had type 2 diabetes [17], overall changes in DBP, HDL-C
and WC were no longer statistically significant (p = 0.07;
p = 0.44; p = 0.40, respectively).
The results of the meta-regression showed that decreases
in DBP were significantly associated with reductions in
WC (r = 0.91; p = 0.001). A non-significant trend was


































































































































































































































































































































































































126 N. Pattyn et al.
p = 0.10) and for WC with HDL-C (r = -0.68; p =
0.06). triglyceride and plasma glucose were not related to
changes in WC (p [ 0.20 for all).
Only one study investigated the effect of dynamic
resistance training on components of the MetS [21]. They
reported a significant reduction of WC (from mean ± SD
111.5 ± 10.8 to 110.1 ± 11.0 cm; p \ 0.05) whereas
HDL-C, triglycerides, plasma glucose, SBP and DBP
remained statistically unaltered (p [ 0.05 for all).
Two trials, involving 33 participants investigated the
effect of combined dynamic endurance and dynamic
resistance training in patients with the MetS [20, 21].
Both trials observed a significant reduction of WC. In
addition, Balducci et al. [20] reported positive findings for
HbA1c (from mean ± SD 7.29 ± 1.35 to 6.34 ± 0.96%;
p \ 0.0001) and HDL-C (from mean ± SD 44.1 ± 2.0 to
47.6 ± 1.85 mg/dL; p \ 0.001) whereas this remained
statistically unaltered in the study of Stensvold et al. [21].
Mean Difference
Study or Subgroup
Watkins et al. [15] −5.00 [−14.60, 4.60] 2003
Gomes et al. [16] −3.00 [−9.56, 3.56] 2008
Tjønna et al. [18] A −6.00 [−22.40, 10.40] 2008
Tjønna et al. [18] B −20.00 [−37.67, −2.33] 2008
Balducci et al. [20] −7.50 [−9.66, −5.34] 2010
Stensvold et al. [21] −7.90 [−24.43, 8.63] 2010
−20 −10 0
Favours experimental Favours control
10 20
Total (95% CI)
Heterogeneity: χ2 = 3.91, df = 7 (p = 0.79); I2 = 0%
Test for overall effect: Z = 7.23 (p < 0.00001)
−7.11 [−9.03, −5.18]
Irving et al. [17] B −6.00 [−19.78, 7.78] 2008
Irving et al. [17] A
−7.00 [−21.57, 7.57] 2008
IC%59,dexiF,VIIC%59,dexiF,VI Year
Mean Difference
Fig. 3 Average net changes and corresponding 95% confidence
intervals for systolic blood pressure. Tjønna et al. [18] A and
B represents moderate continuous training programme and aerobic
interval training programme, respectively; and Irving et al. [17] A and
B represents high-intensity training and low-intensity training,




Dumortier et al. [14] −7.60 [−20.03, 4.83] 2003
Tjønna et al. [18] A −11.50 [−22.89, −0.11] 2008
Irving et al. [17] B 5.10 [−5.84, 16.04] 2008
Irving et al. [17] A 0.60 [−11.10, 12.30] 2008
Stensvold et al. [21] −2.10 [−10.53, 6.33] 2010
Balducci et al. [20] −3.70 [−5.36, −2.04] 2010
−20 −10 0
Favours experimental Favours control
10 20
Total (95% CI)
Heterogeneity: χ2 = 10.78, df = 7 (p = 0.15); I2 = 35%
Test for overall effect: Z = 4.35 (p < 0.0001)
−3.36 [−4.87, −1.84]
Tjønna et al. [18] B −12.90 [−26.90, 1.10] 2008
Gomes et al. [16] 3.00 [−3.56, 9.56] 2008
IC%59,dexiF,VIIC%59,dexiF,VI Year
Mean Difference
Fig. 2 Average net changes and corresponding 95% confidence
intervals for waist circumference. Tjønna et al. [18] A and B represents
moderate continuous training programme and aerobic interval train-
ing programme, respectively; and Irving et al. [17] A and B represents
high-intensity training and low-intensity training, respectively. CI
confidence intervals, df degrees of freedom, IV intervention, v2 Chi-
squared
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Finally, none of the combined exercise studies found a
statistically significant effect on triglycerides, SBP or DBP.
3.4 Secondary Outcomes: Effect of Dynamic
Endurance Exercise on Other Cardiovascular
Risk Factors
As shown in Table 3, dynamic endurance training also
positively affected other blood lipids (LDL-C, total
cholesterol), some anthropometric characteristics (body
weight, BMI) and resulted in a significant increase of
_VO2peak with 19.3% compared with controls.
3.5 Publication Bias
Funnel plots did not show any significant publication
bias for all of the primary and secondary outcomes,
meaning that there was no asymmetric relationship




Watkins et al. [15] 0.03 [−0.23, 0.29]
2003Dumortier et al. [14] 0.31 [−0.01, 0.63]
2003
Gomes et al. [16] −0.07 [−0.17, 0.03] 2008
Tjønna et al. [18] B 0.22 [−0.06, 0.50]
2008Tjønna et al. [18] A 0.26 [−0.03, 0.55]
2008
Stensvold et al. [21] −0.04 [−0.50, 0.42] 2010





Heterogeneity: χ2 = 13.00, df = 8 (p = 0.11); I2 = 38%
Test for overall effect: Z = 4.27 (p < 0.0001)
0.06 [0.03, 0.09]
Irving et al. [17] B 0.09 [−0.22, 0.40]




Fig. 5 Average net changes and corresponding 95% confidence
intervals for HDL-C. Tjønna et al. [18] A and B represents moderate
continuous training programme and aerobic interval training pro-
gramme, respectively; and Irving et al. [17] A and B represents high-
intensity training and low-intensity training, respectively. CI confi-




Watkins et al. [15] −4.00 [−8.90, 0.90] 2003
Gomes et al. [16] 1.00 [−4.61, 6.61] 2008
Irving et al. [17] A −2.00 [−10.62, 6.62] 2008
Tjønna et al. [18] A −7.00 [−19.05, 5.05]
2008
Balducci et al. [20] −5.50 [−6.58, −4.42]
2010Stensvold et al. [21] −4.50 [−13.53, 4.53]
2010
−20 −10 0
Favours experimental Favours control
10 20
Total (95% CI)
Heterogeneity: χ2 = 9.67, df = 7 (p = 0.21); I2 = 28%
Test for overall effect: Z = 9.96 (p < 0.00001)
−5.15 [−6.16, −4.13]
Irving et al. [17] B 2.00 [−7.88, 11.88] 2008




Fig. 4 Average net changes and corresponding 95% confidence
intervals for diastolic blood pressure. Tjønna et al. [18] A and
B represents moderate continuous training programme and aerobic
interval training programme, respectively; and Irving et al. [17] A and
B represents high-intensity training and low-intensity training,
respectively. CI confidence intervals, df degrees of freedom, IV
intervention, v2 Chi-squared
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4 Discussion
The main findings of this meta-analysis suggest that in
patients with the MetS, dynamic endurance training is
associated with favourable effects on most cardiovas-
cular risk factors related to the MetS, that is WC,
HDL-C, SBP and DBP. Our results further demonstrate
that in these patients dynamic endurance training also
favourably affects other important cardiovascular risk
factors including LDL-C, total cholesterol, BMI and
_VO2peak.
It is generally accepted that we need better and more
affordable prevention and treatment strategies to improve
wide-scale cardiovascular health outcome and to prevent
the epidemic of MetS from reaching global proportions and
straining public health and the economy [18]. Exercise is a
key component in the treatment of patients with the MetS
and in the prevention of CVD morbidity and mortality. The
results of this study are in line with previous meta-analyses
and extensive reviews that focused on the effect of exercise
on single risk factors in populations with different cardio-
vascular risk factors [4–7].
Mean Difference
Study or Subgroup
Watkins et al. [15]
0.19 [−1.11, 1.49]
2003Dumortier et al. [14] −1.59 [−3.25, 0.07]
2003
Gomes et al. [16] −0.33 [−1.18, 0.52] 2008
Tjønna et al. [18] B −0.30 [−1.77, 1.17]
2008
Irving et al. [17] A
−0.29 [−0.74, 0.16]
2008
Stensvold et al. [21] −0.20 [−1.70, 1.30] 2010
−2 −1 0
Favours experimental Favours control
1 2
Total (95% CI)
Heterogeneity: χ2 = 2.92, df = 7 (p = 0.89); I2 = 0%
Test for overall effect: Z = 1.90 (p = 0.06)
−0.31 [−0.64, 0.01]
Tjønna et al. [18] A
2008





Fig. 7 Average net changes and corresponding 95% confidence
intervals for plasma glucose. Tjønna et al. [18] A and B represents
moderate continuous training programme and aerobic interval train-
ing programme, respectively; and Irving et al. [17] A and B represents
high-intensity training and low-intensity training, respectively.




Watkins et al. [15] 0.17 [−0.69, 1.03]
2003Dumortier et al. [14] −0.54 [−1.54, 0.46]
2003
Tjønna et al. [18] A −0.30 [−1.77, 1.17] 2008
Gomes et al. [16] −0.16 [−0.73, 0.41] 2008
Irving et al. [17] A −0.73 [−1.85, 0.39] 2008
Balducci et al. [20] −0.03 [−0.19, 0.13]
2010Stensvold et al. [21] 0.10 [−0.68, 0.88]
2010
−2 −1 0
Favours experimental Favours control
1 2
Total (95% CI)
Heterogeneity: χ2 = 3.30, df = 8 (p = 0.91); I2 = 0%
Test for overall effect: Z = 0.72 (p = 0.47)
−0.05 [−0.20, 0.09]
Irving et al. [17] B 0.25 [−1.29, 1.79] 2008
Tjønna et al. [18] B −0.33 [−2.08, 1.42] 2008
IC%59,dexiF,VIIC%59,dexiF,VI Year
Mean Difference
Fig. 6 Average net changes and corresponding 95% confidence
intervals for triglycerides. Tjønna et al. [18] A and B represents
moderate continuous training programme and aerobic interval train-
ing programme, respectively; and Irving et al. [17] A and B represents
high-intensity training and low-intensity training, respectively.
CI confidence intervals, df degrees of freedom, IV intervention,
v2 Chi-squared
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First of all, we observed a significant improvement in
measures of body composition including reduction in
abdominal obesity, assessed by means of WC, body weight
and BMI and a non-significant reduction in fat mass.
Improvements in body composition characteristics are
suggested to be associated with beneficial changes in lipids
and lipoproteins through mechanisms related to insulin
resistance [23, 24]. Indeed, the results of our meta-regres-
sion show a trend (p = 0.06) between changes in WC and
HDL-C. In line with the meta-analysis of Kelley et al. [25],
we observed significant increases in HDL-C and decreases
in LDL-C and total cholesterol, without an effect on tri-
glycerides. Wilson et al. [26] found that an HDL-C level
between 41 and 46 mg/dL (1.06–1.19 mmol/L) for men
resulted in a relative risk (RR) of all-cause death of 1.27
and HDL-C levels between 23 and 44 mg/dL (0.59–
1.14 mmol/L) in an RR of 1.47 for women, compared with
groups with values of more than 55 and 70 mg/dL,
respectively. In our meta-analysis, HDL-C levels rose from
1.05 mmol/L to 1.13 mmol/L in a sex-mixed population,
still showing non-optimal HDL-C plasma levels. However,
it is stated in a meta-analysis of Kelley et al. [25] that a
decrease of 1% in HDL-C would be associated with an
increase in the risk for coronary heart disease of 2–3%.
Assuming that the reverse is true, the approximate increase
of 8% observed in our meta-analysis should decrease the
coronary heart disease risk by 16–24%.
In addition, patients with the MetS do have type 2 dia-
betes or at least have an increased risk for developing it.
Whereas plasma insulin levels remained statistically unal-
tered, we observed a trend towards lower values of mean
plasma glucose following dynamic endurance exercise
(p = 0.06). Earlier, Snowling and Hopkins [27] reported in
patients with type 2 diabetes significant reductions in
fasting glucose, HbA1c and insulin sensitivity after
dynamic endurance training, with some evidence of small
additional benefits resulting from combining endurance
and resistance training. Moreover, it was suggested that the
effects were somewhat larger for those with a more severe
disease status, in particular for HbA1c. The lack of a sig-
nificant effect on glucose-insulin dynamics in the current
meta-analysis might be partly explained by the fact that the
majority of participants were pre-diabetic but did not have
diabetes. Indeed, the study of Balducci et al. [20] in
patients with type 2 diabetes and the MetS did result in
significant decreases in HbA1c after 12 months of exercise
training, which confirms our suggestion. In addition,
measuring plasma glucose and plasma insulin after an oral
glucose tolerance test is often a better marker of changes in
glucose tolerance after an exercise or dietary intervention.
In the study of Watkins et al. [15], significant decreases in
2 h of plasma insulin were found in the dynamic endurance
exercise group but not in the control group after 26 weeks,
while there were no changes in fasting glucose and fasting
insulin.
Following dynamic endurance training, a mean reduc-
tion in BP of 7/5 mmHg was achieved. These mean dif-
ferences are statistically significant but more importantly,
the magnitude of these differences is likely to be clinically
relevant. Results from large, prospective intervention
studies suggested that small reductions in resting SBP and
DBP of 3 mmHg can reduce coronary heart disease risk by
5%, stroke by 8% and all-cause mortality by 4% [28].
Although the observed effect on each of the individual
risk factors might seem small, when we combine all the
effect sizes, that is a BP reduction to a mean of 131/
82 mmHg, a decrease in WC to an average of 101 cm and
for plasma glucose and triglycerides to a mean of 5.67 and












LDL-C (mmol/L) 3.34 -0.38 -0.75, -0.01 p = 0.05 4 60 RE
TC (mmol/L) 5.55 -0.53 -0.64, -0.42 p \ 0.001 5 23 FE
Anthropometric characteristics
Weight (kg) 92.06 -3.51 -5.40, -1.61 p \ 0.001 8 0 FE
BMI (kg/m2) 32.18 -1.65 -2.81, -0.48 p \ 0.01 9 0 FE
FM (kg) 38.73 -1.92 -6.41, ?2.57 NS 4 0 FE
Glucose/insulin parameters
Plasma insulin (mmol/L) 18.68 -0.98 -4.51 to ?2.56 NS 4 0 FE
Other secondary outcomes
_VO2peak (mL/kg/min) 26.61 ?5.86 ?3.03, ?8.69 p \ 0.001 8 58 RE
BMI body mass index, CI confidence interval, FE fixed effect model, FM fat mass, LDL-C low-density lipoprotein cholesterol, NS non-
significant, RE random effect model, TC total cholesterol, _VO2peak peak oxygen uptake
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2.0 mmol/L, respectively and an increase of HDL-C to
1.1 mmol/L, a large number of patients would probably
no longer be classified as having the MetS. Earlier,
Katzmarzyk et al. [29] showed that 30.5% of patients
(mean age 44.7 years) with the MetS at baseline, were no
longer classified as having the MetS after a 20-week
supervised dynamic endurance training programme. This
reduction was mostly due to an improvement in triglycer-
ides (43%), BP (38%) and WC (28%) whereas beneficial
effects on HDL-C and plasma glucose were seen in fewer
patients (16 and 9%, respectively). Similarly, Anderssen
et al. [30] reported that 23.5% of 34 patients no longer had
the MetS after an exercise intervention of 1 year. The only
study included in this meta-analysis reporting on the number
of patients with the MetS showed similar decreases with a
37.5% (from 8/8 to 5/8) and a 45% decrease (from 11/11 to
6/11) following 16 weeks of continuous and interval train-
ing, respectively [18]. Although it is difficult to quantify
exactly the overall risk reduction associated with all
observed changes, these results are compatible with an
overall improvement of cardiovascular risk. Moreover, the
results of this meta-analysis study are supported by studies
that have examined the cross-sectional relationship between
physical activity and the MetS. For example, in 1298 healthy
police employees of the Utrecht Police Lifestyle Interven-
tion Fitness and Training (UPLIFT) study, average physical
activity intensity, average time spent at physical activity,
physical activity volume and physical fitness, were each
associated with reduced odds of the MetS [31]. Taken
together, the results of these studies, and those from the
present meta-analysis, reinforce the notion that physical
activity is an important treatment option for the MetS, as
stated in Katzmarzyk et al. [29].
Finally, low aerobic capacity has been shown to be a
stronger predictor of CVD and mortality compared with
other established risk factors [32]. The five studies that
reported on the effect of dynamic endurance training on
_VO2peak showed a significant mean increase of 6 mL/kg/
min or 19.3%. An increase of one metabolic equivalent
task (=3.5 mL O2/kg/min) in exercise capacity referred to
an RR for all-cause death of 0.84 [33]. Earlier, physical
activity and physical fitness have been shown to be
inversely associated with the clustering of metabolic
abnormalities [31]. With regard to physical activity, it
seems that intensity and more specifically higher intensity
is the main characteristic of physical activity determining
its effect on the combination of CVD risk factors [31].
However, as physical fitness exerted greater effects [31],
this suggests that in daily practice physical activity should
preferably increase physical fitness to maximize its effect
on the prevention of the MetS. This might most likely be
achieved by exercise at higher intensity [31]. Given the
lack of adequate reporting of training characteristics, we
were unable to investigate the effect of intensity in this
meta-analysis. A considerable number of additional studies
will be required to adequately discuss this aspect.
With regard to the effect of other training characteristics
on cardiovascular risk factors in patients with the MetS,
more research is warranted to allow for appropriate exer-
cise prescriptions. That is, only one intervention group
investigated the effect of dynamic resistance training on the
clustering of cardiovascular risk factors in individuals with
the MetS and found that only WC was decreased signifi-
cantly [21]. In a study of Banz et al. [34], with obese
subjects, the effect of dynamic resistance training also
resulted in significant changes in WC, but in no other
significant beneficial cardiovascular effects. Smutok et al.
[35] found significant changes in glucose and insulin
responses after an oral glucose tolerance test was admin-
istered after a dynamic resistance training programme in
individuals with two cardiovascular risk factors, but blood
lipids and lipoproteins or BP outcomes didn’t improve
significantly. It seems that dynamic resistance training has
potential beneficial effects on the cardiovascular risk pro-
file, but that dynamic endurance training is more beneficial
[34, 35]. In a large meta-analysis of Cornelissen et al. [36],
the effect of resistance training on BP and other cardio-
vascular risk factors was reviewed. They found positive
effects on SBP, DBP and _VO2peak, but no changes were
seen in HDL-C, triglycerides and plasma glucose.
The effect of combined exercise on the clustering of
cardiovascular risk factors in patients with MetS was dis-
cussed in two studies [20, 21]. Balducci et al. [20] con-
cluded that combined endurance and resistance training
had larger beneficial effects on upper body strength and
body weight than dynamic endurance training only. No
significant differences were found for the other outcome
measures [20]. Stensvold et al. [21] found slightly larger
benefits for the dynamic endurance training on SBP and
DBP than that of combined exercise. The training
responses were similar for WC, HDL-C, triglycerides and
plasma [21]. However, more research is needed to inves-
tigate the potential benefits of combined training
programmes.
The results of this meta-analysis should be interpreted
within the context of its limitations: First, only one study
fulfilling the inclusion criteria included a dynamic resis-
tance intervention [21], and only two trials used a com-
bined intervention of dynamic resistance training and
endurance training [20, 21]. Further research about the
effect of dynamic resistance training only or in combina-
tion with dynamic endurance exercise training is warranted
in patients with the MetS. Second, a sensitivity analysis
demonstrated that omitting the only trial in which all
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patients had type 2 diabetes [20], the effect of exercise on
DBP, HDL-C and WC were no longer significant
(p = 0.07; p = 0.44; p = 0.40, respectively). The severity
of the MetS risk factors or a pathological state (type 2
diabetes) can probably influence the effects of exercise
training, with more severe CV risk factors resulting in
potentially larger improvements. Third, due to the small
number of study groups, a subgroup analysis for sex or
medication intake was not possible. More research is
needed on the effect of variables that could potentially
affect the outcomes of an exercise programme, especially
the effect of sex and medication. Further, the mean age of
participants was 52 years with a range between 46 and
64 years; therefore it may not be possible to generalize
these results for younger or older individuals with the
MetS. Finally, it has been suggested that one exercise dose
does not fit for all components of the MetS and that
recommendations should vary regarding the different risk
factors [37]. Therefore, it is necessary to strike a balance
for the most optimal exercise programme to improve the
cluster of cardiovascular risk factors in patients with the
MetS.
5 Conclusion
It can be concluded that exercise interventions have ben-
eficial effects on most of the cardiovascular risk factors in
patients with the MetS, but further research is needed to
expand the knowledge and to strengthen the results found
in this meta-analysis.
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